FDA.reportPublic FDA data

Application 075252

Type
ANDA
Sponsor
AAIPHARMA LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001AZASANAZATHIOPRINETABLET;ORAL50MGNoNo
002AZASANAZATHIOPRINETABLET;ORAL25MGNoNo
003AZASANAZATHIOPRINETABLET;ORAL75MGNoNo
004AZASANAZATHIOPRINETABLET;ORAL100MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
51407-182AzathioprineAzathioprineGolden State Medical Supply, Inc.ANDACurrent
51407-182AzathioprineAzathioprineGolden State Medical Supply IncANDACurrent
51407-182AzathioprineAzathioprineGolden State Medical Supply Inc.ANDACurrent
51407-182AzathioprineAzathioprineGolden State Medical SupplyANDACurrent
51407-182AzathioprineAzathioprineGolden State Medical SupplyANDACurrent
65649-231AzasanAzathioprineSalix PharmaceuticalsANDACurrent
65649-231AzasanAzathioprineSalix PharmaceuticalsANDACurrent
65649-231AzasanAzathioprineSalix Pharmaceuticals Inc.ANDACurrent
65649-231AzasanAzathioprineSalix PharmaceuticalsANDACurrent
65649-231AzasanAzathioprineSalix PharmaceuticalsANDACurrent
65649-231AzasanAzathioprineSalix PharmaceuticalsANDACurrent
65649-231AzasanAzathioprineSalix Pharmaceuticals Inc.ANDACurrent
65649-231AzasanAzathioprineSalix PharmaceuticalsANDACurrent
65649-231AzasanAzathioprineSalix PharmaceuticalsANDACurrent
65649-231AzasanAzathioprineSalix Pharmaceuticals Inc.ANDACurrent
65649-241AzasanAzathioprineSalix PharmaceuticalsANDACurrent
65649-241AzasanAzathioprineSalix Pharmaceuticals Inc.ANDACurrent
65649-241AzasanAzathioprineSalix PharmaceuticalsANDACurrent
65649-241AzasanAzathioprineSalix PharmaceuticalsANDACurrent
65649-241AzasanAzathioprineSalix PharmaceuticalsANDACurrent
65649-241AzasanAzathioprineSalix Pharmaceuticals Inc.ANDACurrent
65649-241AzasanAzathioprineSalix PharmaceuticalsANDACurrent
65649-241AzasanAzathioprineSalix PharmaceuticalsANDACurrent
65649-241AzasanAzathioprineSalix Pharmaceuticals Inc.ANDACurrent
65649-241AzasanAzathioprineSalix PharmaceuticalsANDACurrent
68462-502AzathioprineAzathioprineGlenmark Pharmaceuticals, IncANDACurrent
68462-502AzathioprineAzathioprineGlenmark Pharmaceuticals, IncANDACurrent
68462-502AzathioprineAzathioprineGlenmark Pharmaceuticals, IncANDACurrent
68462-502AzathioprineAzathioprineGlenmark Pharmaceuticals, IncANDACurrent
68462-502AzathioprineAzathioprineGlenmark Pharmaceuticals, IncANDACurrent
68462-502AzathioprineAzathioprineGlenmark Pharmaceuticals, IncANDACurrent
68462-502AzathioprineAzathioprineGlenmark Pharmaceuticals, IncANDACurrent
68462-502AzathioprineAzathioprineGlenmark Pharmaceuticals, IncANDACurrent
68462-502AzathioprineAzathioprineGlenmark Pharmaceuticals, IncANDACurrent
68462-502AzathioprineAzathioprineGlenmark Pharmaceuticals, IncANDACurrent
68462-502AzathioprineAzathioprineGlenmark Pharmaceuticals, IncANDACurrent
68462-502AzathioprineAzathioprineGlenmark Pharmaceuticals, IncANDACurrent
68462-502AzathioprineAzathioprineGlenmark Pharmaceuticals, IncANDACurrent
68462-502AzathioprineAzathioprineGlenmark Pharmaceuticals, IncANDACurrent
68462-502AzathioprineAzathioprineGlenmark Pharmaceuticals, IncANDACurrent
71610-306AzathioprineAzathioprineAphena Pharma Solutions - Tennessee, LLCANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
8583ORIG1999-06-07